1.19 and up 70pc on 50c listing

Another bright trading session today:

http://www.universalbiosensors.com

Universal Biosensors is a specialist medical diagnostics company focused on the development, manufacture and commercialisation of a range of in vitro diagnostic tests for point-of-care use.

The point of care blood tests being developed by Universal Biosensors comprise a disposable test strip which is inserted into a small, re-usable handheld meter. Each of the tests under development utilizes an electrochemical sensor at the end of the strip. This sensor is able to detect and measure electrical signals in a sample of blood. The signal is then recorded by the meter and converted into a reading.

$18m offering over subscribed and so much so that a further $4m was placed to the US.

Listed at 50c in two days now $1.00 plus.

Universal Biosensors 50c CDIs open at 80.5c, now 90c
12:16, Wednesday, 13 December 2006

Sydney - Wednesday - Dec 13: (RWE Australian Business News) -
Universal Biosensors Inc (ASX code: UBI) made an impressive sharemarket
debut today when its 50c CHESS Depositary Interests opened at 80.5c and
rose to 90c.
In the first 15 minutes 105,000 CDIs changed hands.
Universal Biosensors is a medical diagnostics specialist focused
on the development, manufacture and commercialisation of a range of in
vitro diagnostic tests for use in a variety of point-of-care settings.
Each of the diagnostic blood tests under development is designed
to produce rapid and quantitative diagnostic results close to the
patient in a number of different settings.
The tests are designed to be fast enough to allow the immediate
adjustment of clinical treatment according to a patient's condition.
Each of the tests in development utilise a known and established
biomarker and a novel, proprietary technology platform to deliver an
accurate and robust response on a 'real time' basis.
Universal Biosensors has a pipeline of products at varying
stages of development, including an immunoassay test for C-reactive
protein which may be used to assist in the diagnosis of certain
inflammatory conditions, and a prothrombin time test used as a test for
monitoring the therapeutic range of the anticoagulant, warfarin.
The company also provides research and development services to
LifeScan (an affiliate of Johnson & Johnson) in the field of blood
glucose monitoring.